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Abstract
Background: Enterococci, and especially multiresistant Enterococcus faecium, are increasingly found colonizing hospitalized
patients. This increased prevalence of colonization is not only associated with an increased prevalence of infections caused
by enterococci, but also by infections with other nosocomial pathogens. In this study we investigated the causality of this
observed relationship, by determining the influence of intestinal colonization with E. faecium on pulmonary defense against
Pseudomonas aeruginosa.
Methodology/Principal Findings: Three groups of mice were tested; 2 groups of mice were pre-treated with vancomycin,
of which one group was subsequently treated by oral gavage of vancomycin-resistant E. faecium (VRE). The third group did
not receive any pre-treatment. P. aeruginosa pneumonia was induced in all mice. Vancomycin treatment resulted in
intestinal gram-negative bacterial overgrowth and VRE treatment resulted in colonization throughout the intestines. All 3
groups of mice were able to clear P. aeruginosa from the lungs and circulation, with comparable lung cytokine responses
and lung damage. Mice treated with vancomycin without VRE colonization displayed modestly increased plasma levels of
TNF-a and IL-10.
Conclusion: Overgrowth of E. faecium and/or gram-negative bacteria does not impact importantly on pulmonary defense
against P. aeruginosa pneumonia.
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Introduction
Hospitalized patients become increasingly colonized with
multiresistant Enterococcus faecium. This is mainly observed in
patients treated with antibiotics not effective against E. faecium on
nephrology, ICU, hematology and transplantation wards [1,2].
Colonization with this opportunistic pathogen not only has been
associated with an increased incidence of infections with E.
faecium [3,4], but also with other nosocomial pathogens including
multiresistant gram-negative bacilli [5,6]. At present it is unclear
whether this association between enterococcal colonization and
the increased incidence of nosocomial infections bears a causal
relationship or is reflective of the immune suppression commonly
observed in hospitalized patients [7]. Previous experimental
studies have supported the first possibility, showing that
a l t e r a t i o n si nt h eh u m a ng a s t r o i ntestinal tract microbiota can
alter the host immune response and that intestinal bacterial
overgrowth, even in the absence of tissue injury or gut ischemia,
can impair systemic immune responsiveness [8,9]. Indeed,
Marshall et al. [9] demonstrated that oral administration of heat
killed Pseudomonas aeruginosa for 21 days reduced the clearance of a
subcutaneous Staphylococcus aureus abscess and suppressed non-
specific immunity, as measured by the delayed-type hypersensi-
tivity response, in rats. In line, Deitch et al. [10] reported a
decreased in vitro lymphocyte mitogenic response and a
diminished ability to control a S. aureus abscess in mice orally
treated with Escherichia coli.
Pseudomonas aeruginosa is a common causative pathogen in
nosocomial pneumonia and lower respiratory tract infections are
the leading cause of death from nosocomial infections [11]. In light
of the association between enterococcal colonization and infection
with other nosocomial pathogens, and the experimental evidence
that alterations in the gut flora may impact on host immunity, we
here investigated the causality of this observed relationship and
demonstrate that intestinal overgrowth with E. faecium does not
influences the pulmonary immune response to P. aeruginosa.
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Mice
Specific pathogen-free 10-wk-old female wildtype C57BL/6
mice were purchased from Harlan Sprague-Dawley (Horst, The
Netherlands). The animals were housed in rooms with a controlled
temperature and a 12-h light-dark cycle. They were acclimatized
for 1 week prior to usage, and received standard rodent chow and
water ad libitum. The Animal Care and Use Committee of the
University of Amsterdam approved all experiments.
Bacterial strains
A vancomycin resistant E. faecium (VRE) strain, E155, was used
in all experiments. This clinical isolate from the Cook County
Hospital, Chicago, IL, belongs to a genetic subpopulation of
hospital-associated E. faecium, currently labeled clonal complex-17
(CC17) that is responsible for the worldwide emergence of
nosocomial multiresistant E. faecium. CC17 is characterized by
high-level quinolon resistance, ampicillin resistance and a recently
identified pathogenicity island, containing the variant esp gene
[12]. For all experiments the bacteria were grown overnight on
agar sheep blood (BA) plates and then grown for approximately
3.5 hours in Todd-Hewitt (TH) broth (Difco, Detroit, MI) to
midlogarithmic phase at 37uC, while shaking. P. aeruginosa (strain
PA01) was grown to mid-logarithmic phase in Luria Bertani
medium (Difco) for 6 h at 37uC.
Experimental design
A mouse model of VRE gastrointestinal colonization was
developed according to the model described by Whitman et al.
[13]. Three groups of mice (N=8 per group) were studied. In
group 1 VRE colonization was established by administering oral
vancomycin (250 mg/ml) in drinking water for 5 days before
gastric inoculation of 10
7 CFU E. faecium suspended in 300 mlT H
medium; control mice (group 2) were treated with oral
vancomycin but received TH medium without E. faecium.
Vancomycin was continued during the entire experiment in both
groups 1 and 2. An additional control group (group 3) was
included without prior vancomycin treatment or E. faecium
colonization. For quantification of intestinal VRE fresh stool was
plated on Slanetz-Bertley (SB) agar plates (Oxoid, Badhoevedorp,
The Netherlands), supplemented with (6 mg/ml) vancomycin.
Additionally, stool samples were plated onto SB agar plates
without vancomycin to enumerate total enterococcal load, and
BA, MacConkey (McC) (Difco, Detroit, MI) and colistin nalidixic
acid (CNA) (BD, Breda, The Netherlands) agar plates for
quantification of total aerobic, facultative gram-negative and
gram-positive bacteria respectively. After 14 days of E. faecium
colonization some mice were sacrificed to check for E. faecium
colonization throughout the intestines, bacterial translocation to
mesenteric lymph nodes (MLN) and histopathology of the
intestines directly prior to induction of pneumonia. Pneumonia
was induced 19 days after initiation of vancomycin treatment
(groups 1 and 2) and 14 days after E. faecium colonization (group 1).
To induce pneumonia mice were lightly anaesthetized with
inhaled isoflurane (Abbott, Queensborough, Kent, UK) and an
inoculum of 5610
6 CFU P. aeruginosa suspended in 50 ml saline
was administered intranasally as described [14,15].
Preparation of blood samples and homogenates
Mice were sacrificed 6, 24 or 48 hours after inducing pneumonia.
They were anesthetized with Hypnorm (Janssen Pharmaceutica,
Beerse, Belgium) and midazolam (Roche, Mijdrecht, The Nether-
lands). Blood was drawn by cardiac puncture, transferred to heparin-
gel vacutainer tubes and immediately placed on ice. Then MLN,
lungs, jejunum, cecum and colon were harvested and homogenized
in 4 volumes of sterile saline with a tissue homogenizer (Biospect
Products, Bartlesville, UK), which was carefully cleaned and
disinfected with 70% ethanol after each homogenization. Blood
was spun down and plasma was collected and frozen at -20uCu n t i l
assayed. For lung and intestinal cytokine measurements lung
homogenates were lysed in 1 volume of lysis buffer (300 mM NaCl,
15 mM Tris, 2 mM mgClH2O, 2 mM Triton X-100, pepstatin A,
leupeptin, and aprotinine (20 ng/ml), pH 7.4) on ice for 30 minutes
and spun down. Supernatants were frozen at 220uCu n t i la s s a y e d .
Determination of bacterial outgrowth
Serial 10-fold dilutions were made of intestinal contents and
each sample of blood, lung and MLN homogenates in sterile saline
and 50 ml of each dilution was plated onto BA plates; intestinal
contents and MLN were also plated on McC, CNA and SB agar
plates. The plates were incubated at 37uC under 5% CO2, and
CFU were counted after 20 hours, or 44 hours for SB plates, and
corrected for the dilution factor.
Typing bacteria by multiple-locus variable-number
tandem repeat analysis
Multiple-locus variable-number tandem repeat (VNTR) analysis
(MLVA) was used to identify VRE from stool as E. faecium strain
E155. The MLVA typing was performed as described previously
[16] (www.mlva.umcutrecht.nl), with the following minor modi-
fications: PCR programs for VNTR-8 and VNTR-9 were similar
to VNTR-7 and VNTR-10, while for VNTR-2 the extension time
was prolonged to 4 minutes instead of 30 s, at 72uC.
Cytokine measurements
Tumor necrosis factor (TNF)-a, interleukin (IL)-6, IL-10 and
monocyte chemoattractant protein (MCP)-1 were measured in
homogenates of lung and intestines and plasma by using a
commercially available cytometric bead array multiplex assay (BD
Biosciences, San Jose, CA) in accordance with the manufacturer’s
recommendations.
Statistical analysis
All data are expressed as mean6SEM. Differences between
groups were calculated by Mann-Whitney U test. For all analysis
GraphPad Prism version 4 (GraphPad Software, San Diego, CA)
was used. A p-value ,0.05 was considered statistically significant.
Results
Intestinal E. faecium colonization
The intestinal track of mice receiving vancomycin in combina-
tion with oral E. faecium was successfully colonized with VRE. In
this experimental group 1, high VRE loads were cultured from
jejunum, cecum and colon directly before induction of pneumonia
(Table 1). These colonies were confirmed E. faecium strain E155 by
MLVA typing. VRE could not be cultured from the intestines of
mice from experimental groups 2 or 3. Enterococci cultured from
stools of control mice, with or without vancomycin treatment,
were identified as Enterococcus faecalis. In vancomycin treated mice
(groups 1 and 2) the gram-negative bacterial load in stool was
almost 1000-fold higher than in untreated mice (group 3) (Table 2).
Similar shifts in the fecal flora in vancomycin treated mice were
seen in jejunum, cecum and colon (data not shown). An increase
was seen in bacterial translocation in the vancomycin treated mice;
2 out of 8 untreated mice showed positive cultures of MLN,
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groups of vancomycin treated mice 5 out of 8 MLN cultured
positive. Three of the VRE colonized mice had VRE positive
MLN. Neither systemic dissemination of bacteria nor an increase
in bacterial translocation after induction of pneumonia was
detected. Upon histopathological analysis of jejunum, cecum and
colon tissue the epithelial cell lining appeared intact and no
remarkable pathology was seen (data not shown). No increases in
cytokine levels were measured in the intestinal homogenates (data
not shown).
Intestinal E. faecium colonization does not impact on the
clearance of P. aeruginosa from the lungs
After 14 days of colonization and 19 days of vancomycin
treatment, mice were intranasally inoculated with 5610
6 CFU P.
aeruginosa. Mice were sacrificed 6, 24 and 48 hours after induction
of pneumonia. In all mice a gradual decrease in the number of P.
aeruginosa CFU was measured in lungs without differences between
VRE colonized mice, mice with intestinal gram-negative over-
growth due to vancomycin treatment but without VRE coloniza-
tion, or mice with normal intestinal flora (Fig. 1). Six hours after
the induction of pneumonia 50% of VRE colonized and 37.5% of
mice in the two other groups had positive blood cultures with P.
aeruginosa (Fig. 1). After 24 hours 25% of mice treated with
vancomycin but without VRE colonization still had positive blood
cultures, although only low amounts of P. aeruginosa were cultured.
Forty eight hours after the infection none of the mice were
bacteremic.
Intestinal E. faecium colonization does not influence the
host response to P. aeruginosa pneumonia
Pseudomonas pneumonia was associated with an increase in the
relative lung weights in all mice, indicative for inflammation and
edema (Fig. 2) [14]. Neither VRE colonization nor gram-negative
intestinal overgrowth influenced this response. In line, no
differences were seen between the three experimental groups with
regard to histopathology: the lungs of all mice showed interstitial
inflammation, edema and pleuritis. Neither VRE colonization nor
intestinal gram-negative overgrowth impacted on the local
cytokine response to Pseudomonas pneumonia. Indeed, no differ-
ences were found between groups with regard to the pulmonary
levels of TNF-a, IL-6, IL-10 or MCP-1 at either 6, 24 or 48 hours
after induction of pneumonia (shown for TNF-a, IL-6 and IL-10
at 6 hours in Fig. 3A–C). Mice treated with vancomycin but not
colonized with VRE had modestly but statistically significantly
higher plasma TNF-a and IL-10 levels 6 hours after the start of
the infection (Fig. 3D–F). Plasma cytokine concentrations were
similar in all groups at 24 and 48 hours after induction of
pneumonia (data not shown).
Discussion
In this study we show that intestinal colonization with a
multidrug- and vancomycin-resistant, clinical isolate of E. faecium
(VRE) does not influence the host response to P. aeruginosa
pneumonia. Colonization with VRE did not result in alterations in
the clearance of Pseudomonas from the lungs, differences in local or
systemic inflammatory cytokine responses or in pulmonary
pathology. Additionally, intestinal gram-negative bacterial over-
growth secondary to vancomycin treatment, although associated
with slightly higher plasma TNF-a and IL-10 concentrations
shortly after induction of pneumonia, did neither influence host
defense or lung pathology during P. aeruginosa pneumonia.
Colonization with multi- and vancomycin- resistant E. faecium is
a growing problem in the hospital setting. Colonization with this
opportunistic pathogen has been associated with an increased
incidence of infections with E. faecium and increased mortality
[3,4,17,18]. Additionally, colonization with VRE has been
associated with infections by other nosocomial pathogens
including multiresistant gram-negative bacilli [5,6]. Many risk
factors for VRE colonization and infection are shared by other
nosocomial pathogens, among which multidrug-resistant gram-
negative bacteria. These factors include preceding antibiotic
exposure, increased severity of illness and increased length of
hospital stay [19,20]. One explanation of the association between
enterococcal colonization and the increased incidence of nosoco-
mial infections could be a common manifestation of the immune
suppression frequently observed in hospitalized patients [7].
Furthermore, patients with an impaired immune system, such as
hematology and transplant patients, are at the highest risk for
acquiring enterococcal infections [21]. In the current study we
sought to obtain insight into the validity of an alternative
explanation, i.e. that colonization of the intestinal tract with
VRE impairs the immune response to P. aeruginosa, a well known
Table 1. Fecal VRE counts in different intestinal
compartments of VRE colonized mice.
Intestinal compartment VRE counts/gram of intestinal contents
Jejunum 2,160.1610
6
Cecum 6,060.9610
8
Colon 9,260.6610
8
Mice were treated with vancomycin (250 mg/ml) in drinking water for 19 days;
VRE was administered by gastric inoculation (10
7 CFU) 5 days after the initiation
of vancomycin treatment. Specimens were obtained 14 days after VRE
instillation. Data are means6SE of 8 mice.
doi:10.1371/journal.pone.0006775.t001
Table 2. Total enterococcal and aerobic gram-negative count in fecal pellets.
Treatment groups Total enterococcal count/gram feces Total gram-negative count/gram feces
Vancomycin and VRE 4.061.3610
9***/{ 1.260.1610
9***
Vancomycin 3.060.4610
5*** 1.460.4610
9***
Untreated 5.560.9610
7 3.960.2610
6
Two groups of mice were treated with vancomycin for 19 days; in one of these, VRE was administered by gastric inoculation (10
7 CFU) 5 days after the initiation of
vancomycin treatment. A third group of mice did not receive vancomycin or VRE. Enterococci, isolated from untreated mice and from mice treated with vancomycin
only, were identified as E. faecalis (i.e. normal inhabitants of the intestines).
***p,0.001 compared to untreated mice, {p,0.001 compared to only vancomycin treated mice (without VRE). Data are means6SE of 8 mice per group.
doi:10.1371/journal.pone.0006775.t002
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result of this study was that the response to respiratory tract
infection with Pseudomonas was virtually identical, despite major
differences in the intestinal flora, for mice colonized and not-
colonized with E. faecium.
Previous experimental studies have shown that alterations in the
flora of the gastrointestinal tract can alter the host immune
response and that intestinal bacterial overgrowth, even in the
absence of tissue injury or gut ischemia, can impair systemic
immune responsiveness [8,9]. Indeed, oral administration of P.
aeruginosa or E. coli impaired host defense against a subcutaneous S.
aureus abscess [9,10], whereas oral gavage of killed P. aeruginosa or
Candida albicans produced significant depression of the delayed-type
hypersensitivity response [9]. In another study [22], peritonitis was
shown to be accompanied by massive small-bowel overgrowth
with E. coli in rats, which contributed to suppression of systemic
immunity. Furthermore, mice orally treated with E. coli demon-
strated a decreased in vitro lymphocyte mitogenic response [10]
and starvation and protein malnutrition disrupted the normal
indigenous gastrointestinal tract microflora in mice, which was
found to impair host antibacterial defenses [23]. In other studies it
was demonstrated that alteration in the gut microflora modulates
the systemic cytokine response to hemorrhagic shock, with
intestinal bacterial overgrowth of monoassociated E. coli leading
to the greatest increase in plasma IL-6 and TNF-a levels [24,25].
Of note, this latter finding is in line with our current data revealing
modestly elevated plasma TNF-a and IL-10 concentrations
6 hours after induction of Pseudomonas pneumonia in mice with
intestinal gram-negative overgrowth without VRE colonization.
In this study, we did not observe an influence of colonization
with E. faecium on the innate immune response to P. aeruginosa
pneumonia. E. faecium, in addition to the most frequently used
genera Lactobacillus and Bifidobacterium, is one of the lactic acid
bacteria (LAB), referred to as probiotics [26]. Probiotics are non-
pathogenic bacteria that are used as functional food components
with claimed health-promoting effects. Several studies have been
performed to investigate the role of intestinal E. faecium on the
immune system in young animals. In two studies performed by
Scharek et al. [27,28] the influence of intestinal colonization by a
non-pathogenic E. faecium strain, SF68, on the immune system was
tested in piglets. They found a reduction in the systemic humoral
immunity (total serum IgG) and a reduction of CD8+ cells in the
intestinal epithelium of the upper jejunum. Contrarily, Benyacoub
et al. [29] found a stimulatory effect of colonization by SF68 on
the immune system, on mucosal and systemic IgA and IgG levels
in dogs. In kittens, Veir et al. [30] found no influence of E. faecium
colonization on the specific or nonspecific immune parameters,
besides an increased percentage of CD4+ cells. Recently, we found
mice first colonized with VRE and subsequently undergoing
Figure 1. Comparable P. aeruginosa clearance from lungs in all treatment groups. Three groups of mice were intranasally inoculated with P.
aeruginosa after different pre-treatment schedules. Two groups of mice were treated with vancomycin for 19 days; in one of these VRE was
administered by gastric inoculation (10
7 CFU) 5 days after the initiation of vancomycin treatment (VRE colonized mice), while in the other group no
VRE was administered (Vancomycin controls). A third group of mice did not receive vancomycin or VRE (Naı ¨ve controls). Percentages of positive
blood cultures at different time points are depicted below the graphic. Data are mean6SEM of 8 mice per group at each time point.
doi:10.1371/journal.pone.0006775.g001
Figure 2. Comparable increase in relative lung weight (mg
whole lung/gram mouse) during P. aeruginosa pneumonia in all
3 groups. Three groups of mice were intranasally inoculated with P.
aeruginosa, after different pre-treatment schedules. Two groups of mice
were treated with vancomycin for 19 days; in one of these VRE was
administered by gastric inoculation (10
7 CFU) 5 days after the initiation
of vancomycin treatment (VRE colonized mice), while in the other group
no VRE was administered (Vancomycin controls). A third group of mice
did not receive vancomycin or VRE (Naı ¨ve controls). Data are mean6
SEM of 8 mice per group at each time point.
doi:10.1371/journal.pone.0006775.g002
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improved infectious and inflammatory outcomes of polymicrobial
peritonitis compared to mice undergoing CLP without the
presence of E. faecium (31). The mechanism by which VRE
colonization and/or infection influenced the host response to
polymicrobial peritonitis remains to be established.
Colonization and infection with multiresistant E. faecium have
been associated with infections by other nosocomial and
multiresistant pathogens. In this study we investigated the
influence of profound intestinal alterations on the pulmonary
response to P. aeruginosa. We showed that colonization with VRE
and/or intestinal overgrowth with gram-negative bacteria does not
impact importantly on the innate immune response to P. aeruginosa
pneumonia. These data argue against the possibility that increased
enterococcal colonization increases the risk of infections by other
nosocomial pathogens by impairing the immune response of the
host. Furthermore, our data also show that alterations in the
intestinal flora do not influence host defense against a common
nosocomial respiratory pathogen.
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